Clinical Trial Update: Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community [NA]

View source ↗

Summary

Completed clinical trial evaluating zoledronic acid (Zometa) for tumor-induced hypercalcemia and malignant bone pain. The study was sponsored by Alberta Health …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Hypercalcemia

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: Alberta Health services | Conditions: Cancer, Hypercalcemia | NA | Status: COMPLETED